Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report issued to clients and investors on Wednesday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of NYSE AMPE opened at $0.00 on Wednesday. Ampio Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $2.91. The company’s 50 day moving average price is $0.01 and its 200-day moving average price is $0.03. The company has a market capitalization of $2,951.00, a P/E ratio of 0.00 and a beta of 3.67.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.